Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Pliant Therapeutics (PLRX) Return on Sales (2020 - 2024)

Pliant Therapeutics has reported Return on Sales over the past 5 years, most recently at 6.88% for Q1 2024.

  • Quarterly Return on Sales fell 660.0% to 6.88% in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 6.88% through Mar 2024, down 675.0% year-over-year, with the annual reading at 1.02% for FY2023, 89.0% down from the prior year.
  • Return on Sales was 6.88% for Q1 2024 at Pliant Therapeutics, down from 1.02% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.0% in Q1 2020 and troughed at 6.88% in Q1 2024.
  • The 5-year median for Return on Sales is 0.17% (2021), against an average of 0.68%.
  • Year-over-year, Return on Sales grew 7bps in 2022 and then plummeted -660bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.04% in 2020, then plummeted by -188bps to 0.12% in 2021, then plummeted by -45bps to 0.18% in 2022, then crashed by -472bps to 1.02% in 2023, then crashed by -574bps to 6.88% in 2024.
  • Per Business Quant, the three most recent readings for PLRX's Return on Sales are 6.88% (Q1 2024), 1.02% (Q4 2023), and 0.44% (Q3 2023).